< Back to Article

APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts

Fig 2

Cumulative incidence curves, adjusting for competing risk of mortality, for dementia by baseline age and APOE-e4 dose.

Note that the strata shown are not independent for the Rotterdam and Framingham cohorts (see text). NACC, National Alzheimer’s Coordinating Center; RS, Rotterdam Study; SALSA, Sacramento Area Latino Study on Aging.

Fig 2